Should You Buy Hexo (TSX:HEXO) Before Upcoming Earnings?

How will Hexo Corp. (TSX:HEXO)(NYSE:HEXO) stock react to its fiscal fourth quarter of 2019 results?

| More on:

One of Canada’s top cannabis companies, Hexo Corp. (TSX:HEXO)(NYSE:HEXO) will be releasing its fiscal fourth quarter of 2019 (ended in July) on October 29. Analysts expect Hexo to post revenue of $25.59 million in the fourth quarter, a rise of 1715% year over year.

Analysts have a high revenue estimate of $27.46 million and a low estimate of $20 million. Hexo reported sales of $1.41 million in the prior-year quarter.

They expect Hexo to post adjusted earnings per share (EPS) of -$0.05 in the fourth quarter. The high EPS estimate stands at -$0.01, while the low estimate is about -$0.11. Hexo reported earnings of -$0.05 in the fourth quarter of 2018.

Hexo has beaten earnings estimates in two of the last four quarters

Hexo investors have had a roller coaster ride. The stock rose from $1.91 in March 2017 to $10.44 in April 2019 and is trading at $5.76 at writing. The stock has fallen over the last few months on concerns over its expensive valuation, weakness in the cannabis industry and regulatory issues plaguing cannabis companies.

Hexo shares have also been hurt, as it has missed earnings estimates in two of the last four quarters. In the third quarter of 2019, Hexo reported earnings of -$0.04, which was 20% above estimates of -$0.05. In the second quarter of 2019, Hexo’s earnings of -$0.02 were 50% higher than estimates of -$0.04.

Hexo reported EPS of -$0.07 in the first quarter, which was 600% below estimates of -$0.01. In the fourth quarter of 2018, Hexo’s EPS of -$0.05 were 150% lower than estimates of -$0.02.

How is Hexo poised for upcoming legalization?

We know that Canada will legalize the consumption of cannabis-based edibles, vapes, beverages and concentrates next month. This may well increase investor optimism, as legalization offers another avenue for cannabis growth.

Hexo Chief Marketing Officer Nick Davies is optimistic about the upcoming legalization. In one Growth Hop report, he states, “Drawing parallels with the technology adoption cycle for new products, the first consumers are led by innovators and early adopters. Once the barriers drop, the leap to majority adoption is not so big. Edibles could have the same effect in the cannabis market, because the perceived risk of trying cannabis is reduced.”

Hexo has also partnered with Molson Coors Canada (TSX:TPX)(NYSE:TAP), forming a joint venture (JV) to develop non-alcoholic, cannabis-infused beverages for the domestic market. While edibles and beverages will be legalized next month, products will hit the markets by mid-December.

The joint venture will form a new company with an independent management team as well as the board of directors. Molson Coors will have a 57.5% stake in the JV and Hexo will have 42.5%.

The two firms are looking to leverage Molson Coors’ expertise in beverage and combine it with Hexo’s cannabis know-how.

The cannabis edibles and vapes segment have the potential to grow rapidly. The edibles are already sold in the U.S., where recreational use is legal. We have seen here that the edibles market is estimated to reach $4.1 billion in 2022, up from $1 billion in 2017.

It will be interesting to see how Hexo moves after its earnings release. The stock has gained 6.4% since the start of September.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned.

More on Cannabis Stocks

Pot stocks are a riskier investment
Cannabis Stocks

Will Canopy Growth Keep the Losing Streak Going in 2026?

Canopy Growth Corp (TSX:WEED) was one of the market's biggest losers in 2025.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

TFSA Investors: An Undervalued Cannabis Stock You Can Buy for $500 Right Now

Down almost 70% from all-time highs, Curaleaf is a TSX cannabis stock that trades at an attractive valuation in December…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2026, as Donald Trump Might Ease Cannabis Restrictions?

Down over 99% from all-time highs, Canopy Growth stock might recover in 2026 if the Trump administration reclassifies cannabis products.

Read more »

Researcher works in hemp field
Cannabis Stocks

Forget Tilray and Buy This Cannabis Stock if the U.S. Reclassifies Marijuana in 2026

While Tilray stock gained over 40% on Friday, this cannabis company is a better buy if the U.S. reclassifies marijuana…

Read more »

A cannabis plant grows.
Cannabis Stocks

Aurora Cannabis Surged 21% on Possible Cannabis Reclassification in the U.S. Is ACB Stock Finally a Good Buy?

Down almost 99% from all-time highs, Aurora Cannabis is a beaten-down marijuana stock that offers upside potential in December 2025.

Read more »

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »